Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

A Call To Service For Clinician Turned Cancer Patient

Just after the New Year in 2017 Duke Cancer Institute physician assistant Scott Balderson, PA, was ordained a deacon in the Episcopal Church — a milestone in a long spiritual journey that's mission, he said, paired perfectly with his 20 years of clinical service to lung cancer patients. “Deacons...

Two-Time Cancer Survivor To Make Strides And Light The Night

In 2004, Cary, North Carolina real estate broker and mother-of-two Mary Ann Feagan, then 47, noticed a lump in the outside corner of her left eyelid. Following a biopsy surgery at Duke, she was diagnosed with a slow-growing type of non-Hodgkin lymphoma and referred to hematologic oncologist Joseph...

DCI Nurse Is Bright Spot For Patients

What does it take to be a great oncology nurse? Joey Misuraca, RN, the nurse manager on the 9100 unit of Duke University Hospital, where seriously ill blood cancer patients are treated, is clear. “What I’m looking for as I hire these new nurses is someone who’s coming out enthusiastic to learn;...

Float Nurse, Cancer Survivor Says A Change Does Him Good

The winds of change—they do blow. This is especially true for Kyle McMichael, RN, an oncology float nurse who on any given day can find himself at a different clinic, hospital floor or cancer center. “I like change,” said McMichael, 28, a native of Columbus, Ohio. “I enjoy that my day is rarely...

Duke Cancer Institute Authorized To Offer Commercial CAR T-Cell Therapy  

On Jan. 31, Duke Cancer Institute joined a select group of medical centers across the country (34 to date) certified and trained to administer Yescarta, the first Food and Drug Administration-approved CAR T-cell therapy for the treatment of adult patients with certain types of relapsed or...

Researchers Identify Genetic Drivers of Most Common Form of Lymphoma

Lymphoma is the most common blood cancer, but the diagnosis belies a wildly diverse and little understood genetic foundation for the disease that hampers successful treatment. An international research effort led by Duke Cancer Institute scientists has been working to better understand the genetic...

DCI Teams Up To Light The Night (Oct. 28)

The 2017 Light The Night walk, hosted by The Leukemia and Lymphoma Society (LLS), will take place Saturday, Oct. 28, at the Booth Ampitheatre in Cary, North Carolina. According to LLS, approximately every three minutes one person in the U.S. is diagnosed with a blood cancer. An estimated combined...

Duke Researchers Reveal Genetic Causes of Rare, But Lethal HSTL

Led by a team from Duke, an international group of 56 researchers has found new mutations identifying potential treatments and new hope for patients with hepatosplenic T cell lymphoma (HSTL or HSCTL) — one of the deadliest cancers known. Through whole exome sequencing of 68 human tissue samples...

Cancer Survivor Steps Out In Fight Against Blood Cancers

After graduating in May 2012 from North Carolina’s High Point University with a Bachelor of Science degree in marketing, Sasha Zabavin moved to New York City for a promising internship with a large retail company. Six months later, on the Friday before Christmas, she was diagnosed with Hodgkin...

Duke Oncologist Going For Woman Of The Year

Man and Woman of the Year candidates compete for the title by raising funds in honor of two local pediatric survivors, a boy and a girl. Boy of the Year Benjamin Byers, photographed here with Woman of the Year candidate Stefanie Sarantopoulous, MD, PhD, was treated at Duke for lymphoblastic...

Sarantopoulos and Dave Awarded LLS Research Grants

The Leukemia and Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to blood cancer, recently awarded grants to two Duke Cancer Institute researchers, Stefanie Sarantopoulos, MD, PhD., and Sandeep Dave, MD, MBA, MS. Sarantopoulos received a Translational Research Program...